The report highlights Ryvu Therapeutics' commitment to transparency, accountability, and sustainability in its operations, from research and development to commercialization and beyond. The report presents the company's key initiatives related to its ESG principles, including its commitment to ethical business practices, environmental protection, employee well-being, and corporate governance. The report also outlines the company's progress in implementing its ESG strategy and its plans for the future.
Issuing Company Ryvu Therapeutics S.A.
Report Type Sustainability Report
Report Language EN
Report Filesize 2.29 MB
No. of Pages 49 pages
Reporting periodDecember 31, 2023
Report EditionUnknown
Assurance Provider Unknown
Reporting Standards Unknown
Materiality Assessmentfalse
